Long-term treatment outcomes of children and adolescents with lymphoblastic lymphoma treated with various regimens: a single-center analysis

BACKGROUND: Lymphoblastic lymphoma (LBL) is the second most common subtype of pediatric non-Hodgkin lymphoma. Modified treatments derived from the LSA2-L2 regimen resulted in encouraging survival, but toxicities and long-term sequelae have been problematic. At present, the acute lymphoblastic leukem...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ho Jung, Shin, Juhee, Kang, Sunghan, Suh, Jin Kyung, Kim, Hyery, Koh, Kyung-Nam, Im, Ho Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784128/
https://www.ncbi.nlm.nih.gov/pubmed/33380561
http://dx.doi.org/10.5045/br.2020.2020220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784128/
https://www.ncbi.nlm.nih.gov/pubmed/33380561
http://dx.doi.org/10.5045/br.2020.2020220

Ejemplares similares